Correlations of serum interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 1, 2011, Pages 15-23

  Wu, Keh Gong ^a   Li, T H ^a,b   Chen, C J ^a   Cheng, H I ^a   Wang, T Y ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Atopic dermatitis; Childhood; Disease activity; Eosinophil cat ionic protein; IL 16; Total IgE

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 16; BIOLOGICAL MARKER; ANTIHISTAMINIC AGENT; CORTICOSTEROID; EMOLLIENT AGENT; PIMECROLIMUS; TACROLIMUS;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HUMAN; LABORATORY TEST; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; BLOOD; EOSINOPHIL; IMMUNOLOGY; LEUKOCYTE COUNT; PHYSIOLOGY; CORRELATION ANALYSIS; DISEASE SEVERITY ASSESSMENT; IMMUNOGLOBULIN BLOOD LEVEL; PATIENT MONITORING; SCORING SYSTEM; SEVERITY SCORING OF ATOPIC DERMATITIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-16; LEUKOCYTE COUNT; MALE;

EID: 79957841240     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400103     Document Type: Article

References (37)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-60. (Pubitemid 36092023)
2. Akdis CA, Akdis M, Bieber T, et al. European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118:152-69. (Pubitemid 43946480)
3. Novak N, Bieber T, Leung DY. Immune mechanism leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112 (S):128-39.
4. Leung DY, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983; 71:47-56. (Pubitemid 13183903)
5. Zachary CB, Allen MH, MacDonald DM. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic dermatitis. Br J Derm 1985; 112:149-56. (Pubitemid 15165805)
6. Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Burger A. Pimecrolimus lead to an apoptosis-induced depletion of T cells, but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol 2005; 115:1276-83. (Pubitemid 40824602)
7. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Nat Acad Sci USA 1994; 91:5109-13. (Pubitemid 24177802)
8. Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immnol 1998; 102:615-50.
9. Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pità O. Circulating interleukin 16 (IL-16) in children with atopic eczema/dermatitis syndrome (AEDS): a novel serological marker of disease activity. Allergy 2002; 57:815-20. (Pubitemid 34970005)
10. Fortina BA, Tonin E, Pigozzi B, Romano I, Michelotto G, Alaibac M. IL-16 serum level in children with atopic dermatitis. Int J Immunopathol Pharmacol 2006; 19:841-5. (Pubitemid 46145047)
11. Masuda K, Katoh N, Okuda F, Kishimoto S. Increased levels of serum interleukin-16 in adult type atopic dermatitis. Acta Derm Venereol 2003; 83:249-53. (Pubitemid 36920597)
12. Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Eisner P. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis-from laboratory parameters to clinical scores. British J Derma 2006; 154:1112-7. (Pubitemid 43727393)
13. Angelova-Fischer I, Bauer A, Hipler UC, et al. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis. British J Derma 2005; 153:767-73. (Pubitemid 41415903)
14. Gebhardt M, Wenzel HC, Hipler UC, Herrmann D, Wollina U. Monitoring of serologic immune parameters in inflammatory skin disease. Allergy 1997; 52:1087-94. (Pubitemid 27496255)
15. Halmerbauer G, Frischer T, Koller DY. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood. Allergy 1997; 52:765-9. (Pubitemid 27346782)
16. Park JH, Choi YL, Namkung JH, Kim WS, Lee JH, Park HJ, Lee ES, Yang JM. Characteristics of extrinsic vs intrinsic atopic dermatitis in infancy: correlation with laboratory variables. British J Derma 2006; 155:778-83.
17. Murat-Susic S, Lipozencic J, Zizic V, Husar K, Marinovic B. Serum eosinophil cationic protein in children with atopic dermatitis. Int J Dermatol 2006; 45:1156-60. (Pubitemid 44560361)
18. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD Index (consensus report of the European Task Force on Atopic dermatitis). Dermatology 1993; 186:23-31.
19. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92(S):44-7.
20. Cruishank W, Kornfeld H, Center D. Interleukin-16. J Leukoc Biol 2000; 67:757-66.
21. Glass WG, Sarisky RT, Vecchio AM. Not-So-Sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. J Interferon Cytokine Res 2006; 26:511-20. (Pubitemid 44289894)
22. Mathy NL, Scheuer W, Lanzendorfer M, Honold K, Ambrosius D, Norley S, Kurth R. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 2000; 100:63-9. (Pubitemid 30242883)
23. Parada NA, Center DM, Kornfeld H, Rodriguez WL, Cook J, Vallen M, Cruikshank WW. Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol 1998; 60:2115-20. (Pubitemid 28119889)
24. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105:860-76. (Pubitemid 30324392)
25. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, Cruikshank WW, Kornfeld H, Center DM, Weiler PF. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemo-attractant factor) and RANTES. J Immunol 1996; 156:3566-70.
26. Bandeira-Melo C, Sugiyama K, Woods LJ, Phoofolo M, Center DM, Cruikshank WW, Weller PF. IL-16 promotes leukotriene C4 and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol 2002; 168:4756-63. (Pubitemid 34441384)
27. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy 2004; 59:561-70. (Pubitemid 38748052)
28. Pucci N, Novembre E, Cammarata MG, Bernardini R, Monaco MG, Calogero C, Vierucci A. Scoring atopic dermatitis in infants and young children: distinctive feature of SCORAD index. Allergy 2005; 60:113-6.
29. Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis? Int J Dermatol 2007; 46:1258-62.
30. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 2004; 15:86-8. (Pubitemid 38327304)
31. Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC. The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis. Mediators Inflamm 2006; 4:73098
32. Dhar S, Malakar R, Chattopadhyay S, Dhar S, Banerjee R, Ghosh A. Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels. Indian J Dermatol Venereol Leprol 2007; 71:246-9. (Pubitemid 41191360)
33. Hon KL, Chan HIS, Chow CM, Wang SS, Lam CWK, Ng PC, Leung TF. Specific IgE of common foods in Chinese children with eczema. Pediatr Allergy Immunol 2010; on line.DOI:10.1111/j.1399-3038.2010.01031.x
34. Mori A, Suko M, Nishizaki Y, et al. Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int Arch Allergy Immunol 1994; 104:S32-5.
35. Oldhoff JM, Darsow U, Werfel T, et al. Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis. Allergy 2005; 60:693-6. (Pubitemid 40562479)
36. Lane JE, Cheyney JM, Lane TN, Kent DE, Cohen DJ. Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol 2006; 54:68-72. (Pubitemid 41832460)
37. Sheinkopf LE, Rafi AW, Do LT, Katz RM, Klaustermeyer WB. Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study. Allergy Asthma Proc 2008; 29:530-7.